183 related articles for article (PubMed ID: 16426222)
1. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs.
Kanae Y; Endoh D; Yokota H; Taniyama H; Hayashi M
Am J Vet Res; 2006 Jan; 67(1):127-33. PubMed ID: 16426222
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
3. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
5. Novel variations and loss of heterozygosity of BRCA2 identified in a dog with mammary tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Nagano M; Tomioka Y; Sasaki N; Hashizume K; Iwanaga T
Am J Vet Res; 2008 Oct; 69(10):1323-8. PubMed ID: 18828690
[TBL] [Abstract][Full Text] [Related]
6. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors.
Hezmee MN; Kyaw-Tanner M; Lee JY; Shiels IA; Rolfe B; Woodruff T; Mills PC
Vet Immunol Immunopathol; 2011 Jan; 139(1):50-6. PubMed ID: 20846729
[TBL] [Abstract][Full Text] [Related]
8. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
9. Loss of p27 expression in canine mammary tumors and their metastases.
Klopfleisch R; Schütze M; Gruber AD
Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone mRNA in mammary gland tumors of dogs and cats.
Mol JA; van Garderen E; Selman PJ; Wolfswinkel J; Rijinberk A; Rutteman GR
J Clin Invest; 1995 May; 95(5):2028-34. PubMed ID: 7738169
[TBL] [Abstract][Full Text] [Related]
11. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma.
Dickerson EB; Thomas R; Fosmire SP; Lamerato-Kozicki AR; Bianco SR; Wojcieszyn JW; Breen M; Helfand SC; Modiano JF
Vet Pathol; 2005 Sep; 42(5):618-32. PubMed ID: 16145208
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
Mayr B; Dressler A; Reifinger M; Feil C
Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
[TBL] [Abstract][Full Text] [Related]
14. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
[TBL] [Abstract][Full Text] [Related]
15. Complementary DNA cloning, tissue distribution, and synthesis of canine brain natriuretic peptide.
Asano K; Murakami M; Endo D; Kimura T; Fujinaga T
Am J Vet Res; 1999 Jul; 60(7):860-4. PubMed ID: 10407480
[TBL] [Abstract][Full Text] [Related]
16. Quantification of MDR-1 gene expression in canine tissues by real-time reverse transcription quantitative polymerase chain reaction.
Culmsee K; Gruber AD; von Samson-Himmelstjerna G; Nolte I
Res Vet Sci; 2004 Dec; 77(3):223-9. PubMed ID: 15276773
[TBL] [Abstract][Full Text] [Related]
17. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
18. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
Lee CH; Kweon OK
J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tissue factor expression in canine tumor cells.
Stokol T; Daddona JL; Mubayed LS; Trimpert J; Kang S
Am J Vet Res; 2011 Aug; 72(8):1097-106. PubMed ID: 21801068
[TBL] [Abstract][Full Text] [Related]
20. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
